INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Fear Isn't A Strategy: Rethinking AI In Clinical Trials
As AI restrictions rise, needed oversight is slowing trials. This piece explores how delays hurt patients and how sites and sponsors can modernize without sacrificing regulatory trust.
-
The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast
Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.
-
New Purpose-Built Facility For Large-Scale Sterile Fill/Finish Operations
Expanding capacity for late-phase clinical and large-scale commercial small molecule and biologic drugs, a new facility boosts sterile fill/finish capabilities.
-
When "Everything" Is The Pain Point: Rethinking RTSM For Real-World Use
RTSM friction often comes from complexity, limited flexibility, and siloed data. Discover approaches that improve visibility, forecasting, and operational efficiency across clinical trials.
-
Tailored Approach Supports Bladder Cancer Breakthrough3/5/2026
Discover how a flexible operational strategy and expert site management help bladder cancer programs overcome complex logistical hurdles and achieve critical regulatory milestones.
-
Transform Your Clinical Trials With Central eSource3/25/2026
Accelerate your trial startup and reduce site burden with a central eSource that allows sponsors to develop and publish central source templates to sites.
-
Consolidating Access Into A Single Platform: A Site CEO's Perspective2/28/2025
By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.
-
How A Small Biotech Partnered With Us To Navigate Trial Complexity With Confidence And Control7/30/2026
Early-phase trials often evolve rapidly. See how a flexible RTSM approach helped a biotech sponsor manage major protocol changes without disrupting study execution.
-
Travel And Payment Services: A Patient's Journey12/5/2025
Streamline patient travel and payments in your clinical trials by implementing centralized, high-quality concierge services that reduce burdens, improve satisfaction, and boost study performance.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
With over 30 years of proven experience, we provide comprehensive clinical pharmacology services, from data management and analysis to the generation of clinical study reports.
-
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
-
Developing cutting-edge treatments for ovarian cancer requires specialized expertise and a people-first approach to research.
-
From regulatory pathway selection to patient recruitment challenges to navigating the volume of data to collect and clean — a rare disease therapy requires an extraordinary amount of coordination.